Predictors of Distress Following Genetic Testing for Breast and Ovarian Cancer
Rachel E. Goldsmith(Children's Hospital of Philadelphia), Christine Rini(Hackensack University Medical Center), Marc D. Schwartz(Guardia Civil), Suzanne C. O’Neill(Georgetown University), Heiðdís Valdimarsdóttir(Reykjavík University)
Cited by 0
Related Papers
The Group-Based Medical Mistrust Scale: psychometric properties and association with breast cancer screening
|Preventive Medicine|2003|495
Depressive symptoms, mental wellbeing, and substance use among adolescents before and during the COVID-19 pandemic in Iceland: a longitudinal, population-based study
|The Lancet Psychiatry|2021|302
Randomized Noninferiority Trial of Telephone Versus In-Person Genetic Counseling for Hereditary Breast and Ovarian Cancer
|Journal of Clinical Oncology|2014|253
Impact of <i>BRCA1</i>/<i>BRCA2</i> Counseling and Testing on Newly Diagnosed Breast Cancer Patients
|Journal of Clinical Oncology|2004|250
Quality-of-Life Effects of Prophylactic Salpingo-Oophorectomy Versus Gynecologic Screening Among Women at Increased Risk of Hereditary Ovarian Cancer
|Journal of Clinical Oncology|2005|239